Skip to main content

Alpha Innotech Expects to Report $3M in Total Q2 Revenue

NEW YORK (GenomeWeb News) - Alpha Innotech expects to report at least $3.15 million in revenues for the quarter ended June 30, marking its fourth consecutive quarter of year-over-year revenue growth, the company said today.
 
The company expects to post more than a 25-percent increase from the $2.51 million in revenues reported in the same period in 2005.
 
"We are on track to attain profitability in the second half of this year and we expect to generate positive cash flow perhaps as soon as next quarter," said Haseeb Chaudhry, CEO of Alpha Innotech, in a statement.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.